Scientific Reviews
Product Guides
Blogs
Topics
Targeted therapy! The Capetin Prize winning "Click Chemistry" can be used like this!Targeted therapy! The Nobel Prize winning "Click Chemistry" can be used like this!2025-02-06
4 Results for "
RM-1
" in MedChemExpress (MCE) Product Catalog:
Products (4)
4 Results for "RM-1" in MCE Product Catalog:
Cat. No.: HY-P991243
Cat. No.: HY-162264
CAS No.: 3032401-72-9
Target:
Research Areas:
Tubulin polymerization/V-ATPase-IN-1 (compound F10) is a Tubulin polymerization/V-ATPase inhibitor. Tubulin polymerization/V-ATPase-IN-1 shows robust antiproliferation activity against four human cancer cell lines, and exerts antiproliferative activity by inhibiting tubulin and V-ATPase. Tubulin polymerization/V-ATPase-IN-1 induces immunogenic cell death in addition to apoptosis, and inhibits tumor growth in an RM-1 homograft model with enhanced T lymphocyte infiltration [1].
Cat. No.: HY-RS14548
Target:
Research Areas:
Tiparp Rat Pre-designed siRNA Set A contains three designed siRNAs for Tiparp gene (Rat), as well as a negative control, a positive control, and a FAM-labeled negative control.
Cat. No.: HY-P703622
Purity: ≥ 95%, as determined by reducing SDS-PAGE.
Synonyms: TIPARP; PARP-1; TCDD Inducible Poly(ADP-Ribose) Polymerase; DDF1; ARTD14; RM1; PARP7; TCDD-Inducible Poly(ADP-Ribose) Polymerase, IsofoRM CRA_b; PARP-7; TCDD-Inducible Poly(ADP-Ribose) Polymerase, IsofoRM CRA_c; PART14; TCDD-Inducible Poly [ADP-Ribose] Po
Species:
Human
Source:
E. coli
-
-
Protocols
Targeted therapy! The Capetin Prize winning "Click Chemistry" can be used like this!Targeted therapy! The Nobel Prize winning "Click Chemistry" can be used like this!A suitable model is crucial in drug screening experiments. Organs can mimic the three-dimensional functional structure of internal organs, have similar spatial organization to corresponding organs, maintain some key characteristics, and reproduce some physiological functions. They are widely used for modeling and personalized drug screening physiological functions.2025-02-06
